%PDF-1.4
%
7 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
5 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
6 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
3 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
8 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
9 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
10 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
4 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
1 0 obj
<>>>/BBox[0 0 609.45 793.7]/Length 56>>stream
xs
w3T04PI2P0T5T0 q-,LBr44C@ i s
I-
endstream
endobj
12 0 obj
<>stream
application/pdf10.1080/14740338.2016.1238067application/pdf10.1080/14740338.2016.1238067enIncidence and implications of chemotherapy related hand-foot syndrome
V. NikolaouK. SyrigosM. W. Saif
Taylor & Francis
Expert Opinion on Drug Safety, 2016. doi:10.1080/14740338.2016.1238067
Hand-foot syndromepalmoplantar erythrodysesthesiachemotherapycapecitabine5-fluorouracil
10.1080/14740338.2016.1238067http://dx.doi.org/10.1080/14740338.2016.12380672016-10-08truewww.tandfonline.com10.1080/14740338.2016.1238067www.tandfonline.comtrue2016-10-0810.1080/14740338.2016.1238067application/pdf10.1080/14740338.2016.1238067enIncidence and implications of chemotherapy related hand-foot syndrome
V. NikolaouK. SyrigosM. W. Saif
Taylor & Francis
Expert Opinion on Drug Safety, 2016. doi:10.1080/14740338.2016.1238067
Hand-foot syndromepalmoplantar erythrodysesthesiachemotherapycapecitabine5-fluorouracil
JournalExpert Opinion on Drug Safety© 2016 Informa UK Limited, trading as Taylor & Francis Group1474-03381744-764X00001910.1080/14740338.2016.1238067http://dx.doi.org/10.1080/14740338.2016.1238067
VoR
2016-10-07T02:36:25+05:30Arbortext Advanced Print Publisher 11.0.3352/W Unicode2016-10-10T06:26:25-07:002016-10-10T06:26:25-07:00
Hand-foot syndrome; palmoplantar erythrodysesthesia; chemotherapy; capecitabine; 5-fluorouraciliText 4.2.0 by 1T3XT
uuid:a028b635-e74c-4d03-b19c-f7fbeea98a9duuid:61629156-d803-420d-933c-cb99a3f952ae
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi y+
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS*
R
endstream
endobj
29 0 obj
<>stream
x+ |
endstream
endobj
30 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
34 0 obj
<>stream
xZK5ϯ#Vڝq%L ?r~IJVOUu^2C |xůAC҉ps.XUK7Pk5EݟW1<+W*U.c#Cg%_ØM{nwy/k}1WhsDϷq\#s~Y,h|tKbqAcfFOQ+$f}:@-<xبvDH;öHɐy㴺JY'Tqy4*U2Q9~y_>Q>{4 Ov;`¼7FHӨtw~O/LWTk)AgQVh\!WgC6G\|5/u(֨9v($otD՜tZ@Azmx>WR#\> ZTIx,h/pFq
ei:pՎ(iуY8dM(@D\p!m\ZB:o8љ{NrV{qxx\